SITC Cancer Immunotherapy CONNECT

sitc_log_color.png

Women in Cancer Immunotherapy Network Leadership Institute

Seattle on Aug. 19–20, 2019
Empowering women in the cancer immunotherapy field

Apply by April 15 to attend this free program.

LEARN MORE

cig-big.png

Call for Comment: SITC Head and Neck Cancer Immunotherapy Guidelines
"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)"

Comments due on Sunday, April 14 by 11:59 p.m PST.

Request a Manuscript Today

aci17-cmyk.png
Are you up to date with I-O?
Attend an upcoming SITC Advances in Cancer Immunotherapy™ Program


Salt Lake City Toronto | New Orleans

 



aci17-Online-clr.png
2019 Lung Cancer and Immunotherapy Course 
A free, interactive course, part of the Advances in Cancer Immunotherapy™ online education series.

Register Now



Small_Hwu_Carousel.jpg

Why I'm a SITC Member

Join Leisha A. Emens, MD, PhD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.

Become a SITC Member

sitc_log_color.png

SITC-ONS Joint Session at ONS Congress
SITC and Oncology Nursing Society will host a joint session, Checks & Balances: Cancer Immunotherapy for the Advanced Practice Nurse, during ONS Congress on April 10 in Anaheim, Calif.

LEARN MORE

FFlogo

Inspire the Next Generation of Cancer Immunotherapy Leaders

Advance the science of cancer immunotherapy and help young investigators tackle hurdles facing the field with a gift to the SITC Forward Fund.

Donate Today


 

Now Available:
SITC 2018 Enduring Materials

ACCESS OR PURCHASE Slides and Videos TODAY

sitc_log_color.png

Meet-the-Expert Webinar: How to Kick-Start Your Career in the US

Register today for this free webinar to learn strategies and tactics for how to kick-start your career in the US on April 16 from 1–2 p.m. EST.

LEARN MORE

Patient

Explore resources and educational opportunities for cancer patients and those who advocate for them.

Explore

 

 

 

 

Clinician

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.

Explore

 

 

 

 

Researcher

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.

Explore

 

 

 

 

Latest Discussions

  • For those of you in the Philadelphia area, CAR-T and The Rise of the Cellicon Valley Thursday, May 9 and Friday, May 10, 2019 World experts in CAR T-cellular therapy and hematopoietic stem cell transplantation (HSCT) have been assembled to ...

  • Posted in: Women in SITC

    Hi Priscila, Thanks for the info. Sounds like a great opportunity especially for junior faculty.  ------------------------------ Mridula George MD Assistant Professor Rutgers Cancer Institute of New Jersey New Brunswick NJ ------------------------- ...

  • Posted in: Women in SITC

    For those who couldn’t attend, can we get a debrief on interesting data that was presented? I am personally interested in thyroid, thymus, mesothelioma- Thanks! NS Sent from my iPhone The information contained in this electronic e-mail transmission ...

Follow the SITC Twitter Feed.

 

Connect with colleagues at these Upcoming Events.

 


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

 

Learn More

 

The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More